Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

NCT00490009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Bexxar
DRUG: Acetaminophen
DRUG: Diphenhydramine
DRUG: Potassium Iodide (KI)

Sponsor

Susan Knox

Collaborators

[object Object]
[object Object]